Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GEO accession GSE226668 is currently private and is scheduled to be released on Jun 30, 2026.

ABSTRACT: GEO accession GSE226668 is currently private and is scheduled to be released on Jun 30, 2026.

PROVIDER: PRJNA941203 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

TMAO treated human vascular smooth muscle cells

Project description:We utilized human aortic vascular smooth muscle cells (HAVSMCs) treated with saline or trimethylamine N-oxide (TMAO) for 5 hours

2023-01-02 | GSE200143 | GEO

TMAO treated human vascular smooth muscle cells

Project description:TMAO treated human vascular smooth muscle cells

| PRJNA823056 | ENA

RNA-Seq analysis TMAO effect on vascular smooth muscle cells

Project description:Thoracic aneurysm/dissection (TAAD) is a life-threatening condition that lacks effective pharmacotherapeutic treatment. Vascular smooth muscle cells (VSMCs) phenotype switch and extracellular matrix (ECM) degradation has been thought to be critical to the development of TAAD. Trimethylamine N-oxide (TMAO), a metabolite produced by gut microorganisms, is tied with various risk factors for cardiovascular disease, however direct correlation with TAAD remains elusive. RNA-seq analysis TMAO targets identified a cohort of genes, critically involved in the ECM signaling.

2026-06-30 | GSE226668 | GEO

Effect of IL-17 on human vascular smooth muscle cells

Project description:Investigate the effect of recombinant human IL-17A on vascular smooth muscle cells cultured from human aortas. Keywords: Dose response

2008-06-28 | GSE11367 | GEO

Effect of BMPR2 mutation on vascular smooth muscle gene expression

Project description:BMPR2 mutation is the cause of most hereditary pulmonary arterial hypertension, but the common molecular consequence of different types of BMPR2 mutation is still not known. The goal of this study was to determine the common molecular consequences of three different classes of patient-derived BMPR2 mutation in vascular smooth muscle gene expression. Three different classes of BMPR2 mutation, wild-type BMPR2, or empty vector were stably transfected into A7R5 vascular smooth muscle cells, and expression compared.

2010-08-25 | E-GEOD-21573 | biostudies-arrayexpress

LncVSM (AK098656) down-regulation in Vascular Smooth Muscle cells

Project description:The full length of LncVSM transfected into Vascular Smooth Muscle cells to down-regulation for screening differential expression prolifes of LncVSM effecting.The empty vector transfected Vascular Smooth Muscle cells as controls. Eight Samples analyzed.

2016-01-12 | E-GEOD-76720 | biostudies-arrayexpress

RNA-Seq analysis SIRT6 knockdown effect on vascular smooth muscle cells

Project description:Vascular smooth muscle cells (VSMCs) phenotype switch has been thought to be critical to the development of thoracic aneurysm/dissection. To investigate the function SIRT6 in the regulation of VSMCs phenotype switch, we established mouse vascular smooth muscle cells in which each target gene has been knocked down by siRNA.

2024-12-11 | GSE246209 | GEO

RNA-Seq analysis Ezh2 knockdown effect on vascular smooth muscle cells

Project description:Vascular smooth muscle cells (VSMCs) phenotype switch has been thought to be critical to the development of thoracic aneurysm/dissection. To investigate the function EZH2 in the regulation of VSMCs phenotype switch, we established mouse vascular smooth muscle cells in which each target gene has been knocked down by siRNA.

2023-12-16 | GSE227177 | GEO

RNA-Seq analysis HDAC9 knockdown effect on vascular smooth muscle cells

Project description:Vascular smooth muscle cells (VSMCs) phenotype switch has been thought to be critical to the development of thoracic aneurysm/dissection. To investigate the function HDAC9 in the regulation of VSMCs phenotype switch, we used siRNA knockdown of HDAC9 in human aortic smooth muscle cells (HASMC)we established Human aortic smooth muscle cells (HASMCs).

2024-12-31 | GSE228573 | GEO

YAP/TAZ in vascular smooth muscle

Project description:YAP/TAZ in vascular smooth muscle

| PRJNA610067 | ENA